KMK logo

Kromek Group plc Stock Price

AIM:KMK Community·UK£42.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

KMK Share Price Performance

UK£0.065
0.01 (16.07%)
UK£0.065
0.01 (16.07%)
Price UK£0.065

KMK Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

3 Risks
3 Rewards

Kromek Group plc Key Details

UK£26.5m

Revenue

UK£5.1m

Cost of Revenue

UK£21.4m

Gross Profit

UK£17.7m

Other Expenses

UK£3.8m

Earnings

Last Reported Earnings
Apr 30, 2025
Next Reporting Earnings
n/a
0.0057
80.85%
14.16%
0.9%
View Full Analysis

About KMK

Founded
2003
Employees
162
CEO
Arnab Basu
WebsiteView website
www.kromek.com

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company also provides advanced imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, D-Matrix gamma ray imager, and photon-counting spectral CT systems. In addition, it offers products and components for the security and defence markets, including UAV radiation mapping drones, alpha beta probes, radiation detectors, gamma and neutron detectors, D5 RIID, backpack with radiation detection, static node, tactical deployment detector charging station, and vehicle mounted radiation detector, as well as a range of gamma spectroscopy software that enables specialized analysis of samples. Further, the company provides CZT imaging research development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, and internationally. The company was founded in 2003 and is headquartered in Sedgefield, the United Kingdom.

Recent KMK News & Updates

Kromek Group (LON:KMK) Shareholders Will Want The ROCE Trajectory To Continue

Oct 28
Kromek Group (LON:KMK) Shareholders Will Want The ROCE Trajectory To Continue

Recent updates

No updates